TherapeuticsMD TXMD
NASDAQ TXMD
$1.85 -0.05 (-2.63%)
At close: Oct 22, 2026 · 4:00 PM EDT

TherapeuticsMD (TXMD) Price to Earnings (2022 - 2026)

Updated

TherapeuticsMD's Price to Earnings came in at 130.61 for Q1 2026.

Analysis

TherapeuticsMD (TXMD) Price to Earnings (2022 - 2026) Analysis & Trends

For FY2022, TherapeuticsMD's Price to Earnings was 0.47.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 TherapeuticsMD 21.59 Mn 21.59 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 130.61
Sep 30, 2025 41.39
Sep 30, 2023 0.47
Jun 30, 2023 1.02
Mar 31, 2023 0.23
Dec 31, 2022 0.47
API Access

TherapeuticsMD Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=TXMD&period=max&api_key=YOUR_API_KEY